Kantar, C. Et Al. 2021. New Potential Monotherapeutic Candidates for Helicobacter pylori: Some Pyridinazo Compounds Having Both Urease Enzyme Inhibition and Anti-Helicobacter pylori Effectiveness. PHARMACEUTICAL CHEMISTRY JOURNAL , vol.55, no.3 , 246-252.

Kantar, C., Baltaş, N., Alpay Karaoğlu, Ş., & Şaşmaz, S., (2021). New Potential Monotherapeutic Candidates for Helicobacter pylori: Some Pyridinazo Compounds Having Both Urease Enzyme Inhibition and Anti-Helicobacter pylori Effectiveness. PHARMACEUTICAL CHEMISTRY JOURNAL , vol.55, no.3, 246-252.

Kantar, CİHAN Et Al. "New Potential Monotherapeutic Candidates for Helicobacter pylori: Some Pyridinazo Compounds Having Both Urease Enzyme Inhibition and Anti-Helicobacter pylori Effectiveness," PHARMACEUTICAL CHEMISTRY JOURNAL , vol.55, no.3, 246-252, 2021

Kantar, CİHAN Et Al. "New Potential Monotherapeutic Candidates for Helicobacter pylori: Some Pyridinazo Compounds Having Both Urease Enzyme Inhibition and Anti-Helicobacter pylori Effectiveness." PHARMACEUTICAL CHEMISTRY JOURNAL , vol.55, no.3, pp.246-252, 2021

Kantar, C. Et Al. (2021) . "New Potential Monotherapeutic Candidates for Helicobacter pylori: Some Pyridinazo Compounds Having Both Urease Enzyme Inhibition and Anti-Helicobacter pylori Effectiveness." PHARMACEUTICAL CHEMISTRY JOURNAL , vol.55, no.3, pp.246-252.

@article{article, author={CİHAN KANTAR Et Al. }, title={New Potential Monotherapeutic Candidates for Helicobacter pylori: Some Pyridinazo Compounds Having Both Urease Enzyme Inhibition and Anti-Helicobacter pylori Effectiveness}, journal={PHARMACEUTICAL CHEMISTRY JOURNAL}, year=2021, pages={246-252} }